Top Doctor Top Doctor
The Top Doctor award is a peer-nominated award for providers who give exceptional care.

Jonathan L. Wright, MD, MS

Seattle Cancer Care Alliance
Paul H. Lange, MD Endowed Professorship in Urological Oncology; Associate Professor, Department of Urology
University of Washington School of Medicine
Medical Director, Urology Clinic at UW Medical Center - Montlake
UW Medicine
Associate Professor, Public Health Sciences Division
Fred Hutchinson Cancer Research Center
“My goal is to provide the highest level of medical and surgical care in a compassionate environment where each patient is an active member of the team.”
— Dr. Wright
What do you think patients notice about how you and your team work together?

One of the things I routinely hear from patients is that they are blown away by the kindness of the people treating them. It’s because we truly care about what we’re doing — the doctors, nurses, medical assistants, front desk people, everyone. By combining clinical care with research, we’re helping to offer options you can’t get other places. That excites us and makes us all proud to be working here.

What is your approach to care?

We always remember that we’re not treating a disease, we’re treating a person. And we need to figure out which treatments best fit that particular person. This very individualized approach is so important. For instance, there’s a subset of bladder cancer patients who are candidates for bladder preservation, meaning they can avoid surgery and have chemotherapy and radiation therapy instead. Even though I perform bladder removal surgeries, one of my goals is to help more people keep their bladders whenever I can. We look at all your options to figure out the right treatment plan for you. 

Provider background

Specialty: Surgery

Genitourinary cancers, urologic care

Urology includes both medical and surgical treatment. I focus on the oncology side of urology because I appreciate being able to offer both these aspects of care to people with genitourinary cancers. As a urologist with SCCA, I screen people for tumors, perform biopsies, counsel patients about their treatment options, perform surgical removal of tumors and provide follow-up care and cancer surveillance. This gives me the opportunity to develop long-term relationships with my patients and their families, which is a great joy for me. My surgical work includes performing minimally invasive robot-assisted surgeries, such as robotic prostatectomies, robotic cystectomies, robotic partial nephrectomies and robotic inguinal lymph node dissections. 

Diseases treated

Education, experience and certifications
Undergraduate Degree
Boston College
Medical Degree
University of Washington School of Medicine
University of Washington, Urology
University of Washington, Urologic Oncology
Board Certification
Urology, 2011, American Board of Urology
MS, Epidemiology, University of Washington School of Public Health
Seattle Met's 2021 Top Doctors Award

Dr. Wright has been recognized as a Top Doctor in Seattle Met's annual survey multiple years in a row.

Seattle Magazine's 2021 Top Doctors Award

Dr. Wright has been recognized as a Top Doctor in this peer-nominated award multiple years in a row.

Castle Connolly America’s Top Doctors and America’s Top Doctors for Cancer

Dr. Wright received this national Top Doctor award in 2018.

UW School of Medicine’s 2016 Alumni Early Achievement Award

Dr. Wright received this award in June 2016 for significant contributions as a surgeon researcher.

Stories and testimonials

From out of the blue comes a better bladder-cancer detector
From out of the blue comes a better bladder-cancer detector

UW Medicine urologists with Seattle Cancer Care Alliance (SCCA) possess a mechanism that makes the tumors glow bright pink – all the better to see them.

“Dr. Wright is a dedicated, patient-centered physician. He puts a lot of thought into creating cancer management plans and demonstrates technical excellence in surgical care. He’s someone I would be happy to send friends and family to. ”
— John Gore, MD, MS, FACS


Clinical trials

We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.

Study ID:
A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
Complete title
A Randomized Phase 2 Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Subjects Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) and FGFR Mutations or Fusions
Study ID:
Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by Surgery
Complete title
A Randomized Phase III Double-Blind Clinical Trial Evaluating the Effect of Immune-Enhancing Nutrition on Radical Cystectomy Outcomes
Study ID:
Study of Pembrolizumab (MK-3475) in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)
Complete title
A Phase II Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Subjects with High Risk Non-muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy


Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.


SCCA providers are often asked to give their medical expertise for press and news publications. Read articles by or about this SCCA provider.

Blue-Light Cystoscopy: An Innovative Technology to Detect Non-Muscle-Invasive Bladder Cancer

SCCA’s Jonathan L. Wright, MD, spoke with Managed Healthcare Executive about blue-light cystoscopy, an innovative bladder cancer tumor detection method available at SCCA .

Grivas and Wright Weigh In on the Benefits of Multidisciplinary Care in Bladder Cancer

SCCA’s Petros Grivas, MD, PhD and Jonathan L. Wright, MD, MS, discussed the Seattle Cancer Care Alliance Bladder Cancer Multidisciplinary Clinic and shared data that supports the use of a multidisciplinary approach in bladder cancer.

Your care team

At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Registered nurse (RN)
Registered nurse (RN)
Your nurse manages your care alongside your physician and assists with care procedures and treatments.
Team coordinator (TC)
Team coordinator (TC)
Your team coordinator works closely with you and your physician and serves as your scheduler.


SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.

For providers